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Background
Cardiac involvement of sarcoidosis (CIS) is clinically
evident in 5% of patients with systemic sarcoidosis, but
CIS are reported to be found at autopsy in 30% to 50%.
Some of CIS represents remission and recurrence in
clinical setting, and it is difficult to diagnose CIS in
cured condition.
Purpose
We assess whether LGE on CMR reflect CIS in patients
with extracardiac sarcoidosis or suspect of CIS due to
cardiac symptoms.
Methods
Forty-three patients (male/female = 12/31, age 30-78
years) with rule out or suspect of CIS with extracardiac
sarcoidosis and suspect of CIS without extracardiac sar-
coidosis underwent CMR examination. We diagnosed
CIS using Diagnostic Standard and Guideline for Sarcoi-
dosis 2006 of the Japanese Society of Sarcoidosis and
Other Granulomatous Disorders (2006 criteria) as a
gold standard, and subjects were divided into CIS which
including suspect of CIS (s/o CIS) and without CIS. We
defined CIS as fully satisfied of 2006 criteria, and s/o
CIS as follows; satisfied with 1 major and 1 minor of
2006 criteria of CIS with systemic sarcoidosis findings
and satisfied with clinical diagnostic criteria of CIS but
lack of systemic sarcoidosis findings.
We performed visual segment analysis using standard
AHA 17-segments model. The LGE were assessed in
each segment, localization (5 patterns: endocardial, mid-
wall, epicardial, transmural, and multiple), distribution
(3 types: patchy, linear as within 50% of myocardial
thickness and band-like as greater than 50% of myocar-
dial thickness), and signal intensity (2 types; lightly,
definitively).
Results
In all 43 patients, 28 patients (65%) showed LGE on
CMR. According to the 2006 criteria, 31 patients (72%)
divided into CIS including 7 patients of s/o CIS. In CIS,
26 patients (84%) had LGE, and 5 patients (16%) were
luck of LGE. The sensitivity, specificity, positive predic-
tive value and negative predictive value of the LGE were
84%, 83%, 92% and 67%, respectively.
Segment analysis of the LGE (n = 442 seg., 26
patients), in localization; epicardial (92 seg., 21patients),
transmural (59 seg., 15 patients), endocardial (20 seg., 9
patients), mid-wall (15 seg., 6 patients), and multiple
(5 seg., 4 patients) were observed, respectively. In distri-
bution; linear (90 seg., 23 patients), band-like (92 seg.,
17 patients) and patchy (4 seg., 4 patients), respectively.
And signal intensity, definitively (186 seg. 21 patients)
and lightly (18 seg. 8 patients).
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Conclusion
LGE on CMR is a useful diagnostic findings to deter-
mine cardiac involvement of sarcoidosis.
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